ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,140 | +48001.4% | 28,034 | -7.8% | 0.02% | -48.7% |
| Q2 2023 | $651 | -47.4% | 30,414 | -0.5% | 0.04% | -48.7% |
| Q1 2023 | $1,237 | -15.1% | 30,579 | -2.4% | 0.08% | -15.6% |
| Q4 2022 | $1,457 | -100.0% | 31,329 | -55.5% | 0.09% | -62.5% |
| Q3 2022 | $3,648,000 | -0.3% | 70,324 | -9.2% | 0.24% | +5.7% |
| Q2 2022 | $3,660,000 | -50.8% | 77,420 | -25.9% | 0.23% | -42.5% |
| Q1 2022 | $7,438,000 | -2.5% | 104,494 | +2.4% | 0.40% | +5.3% |
| Q4 2021 | $7,632,000 | +11.7% | 102,064 | -15.1% | 0.38% | +4.5% |
| Q3 2021 | $6,831,000 | +24.8% | 120,240 | -3.3% | 0.36% | +22.9% |
| Q2 2021 | $5,474,000 | -2.6% | 124,380 | +9.2% | 0.29% | -13.6% |
| Q1 2021 | $5,620,000 | – | 113,940 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |